Biotech Press Releases

The global diabetes insulin delivery pen market size was valued at USD 17.7 Billion in 2023 and is likely to reach USD 28.7 Billion in 2032, expanding at a CAGR 5.5% during the forecast period.

A 250 million year old dragon fossil was added to the PermianMuseum.com "On the Origin of Life and Biodiversity"  free online book.

15,000 smiles and counting: OneSolution® Dental Implant Centers marks an important milestone in the number of life-changing full-mouth implant procedures performed for patients, setting the standard of care expected in South Florida.

Ventura & Associates HTA Advisors is thrilled to announce its joining of the Microsoft AI Cloud Partner Program and the Microsoft Fabric Community.

Tracks recent competitive developments, approaches, recent industry developments, mergers & acquisitions, collaboration deals, partnership deals, distribution, exclusive, and licensing agreement

Market dynamics indicate a continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$2.8 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 10.5%

Discover how AI is transforming clinical research at ISCR 2025, with Clinion at the forefront of innovation and patient engagement.

Clinion has been recognised with the prestigious SCDM Innovation Award for Clinical Data Science Implementation Excellence at the 2024 SCDM Annual Conference in Boston.

The United States proton therapy market size was valued at USD 1 billion in 2024 and is projected to hit around USD 2.5 billion by 2033, growing at a CAGR of 12% during the forecast period 2025 to 2033.

Immunology Consultants Laboratory, a leading provider of innovative antibodies and immunoassays, is excited to announce the appointment of Dr. Eric McIntush as its new Chief Executive Officer (CEO), effective January 13, 2025. Dr.

$NRXP $31 Price Target from Respected Investment Analyst D. Boral Capital

Milestone Positions Company for Broader Clinical Adoption and Strategic Growth

Maureen L. Mulvihill, Ph.D., President & CEO of Actuated Medical, has been named Chair of the Industrial Advisory Board for the Penn State Center for Biodevices. A founding member of the board since its inception in August 2020, Dr.

$NRXP New Drug Application for Treatment of Suicidal Depression. Completion of NDA Filing Expected in First Quarter of 2025

NRx Pharmaceuticals, Inc.: Stock Symbol: NRXP IS Aiming to be the First FDA-Approved Medication to Treat Suicidal Depression

Ace Therapeutics launches its innovative in vivo models of diabetes mellitus to enhance diabetes research endeavors.

Collaboration, Innovation and Enhancing Quality in Clinical Trials Conference & Expo

"Emergence of Digital Technologies in Pharmaceutical Industry"

OneSolution® Dental Implant Centers now offers a Lifetime Warranty on its OneSolution® Zirconia Hybrid teeth, giving patients confidence in their dental restorations.

Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development.

Liquid biopsy represents an innovative approach to cancer diagnosis and treatment, providing critical insights through non-invasive means.

NAD, What it is and why it is essential as we age? Dr.Abhay K Pati, CEO Biotechayur Pvt Ltd, Odisha, India

Monk Fruit, A natural Sweetener Dr.Abhay Kumar Pati, An Integrated Physician, Author of books on medicinal Plants, Function Food, Global  Traveler, Industrialist, Researcher on Natural living and Life Style, Hayward, CA, USA Monk fruit, also known...

$RENB is working with large $NVDA partner Nebul developing AI and Biotechnology Platforms for Early Diagnosis, Better-Targeted Treatments and Drug Discovery

Eva Garland Consulting (EGC), a leading provider of strategic services for securing non-dilutive funding and advancing science, celebrated North Carolina's thriving innovation ecosystem with a holiday party held on December 5th.

Trials have the potential to fast-track treatment options for patients with limited therapeutic alternatives

Enhanced Features and Streamlined Navigation to Support Surgeons, Eye Banks, and Research Facilities Worldwide.

Dr. James Fetsch, general dentist and full-arch specialist, recently became a keynote speaker for the Full Arch Growth Conference in Orlando, FL, an event focused on growing full-arch dental implant practices worldwide. Dr.

Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study.

Today, the Arizona Pharmacy Association (AzPA), the leading voice for Arizona's pharmacy professionals, announced the appointment of Garet Turner as its new Chief Executive Officer.

OneSolution® Dental Implant Centers is now providing innovative zygomatic dental implant solutions, offering hope to patients who have been told they don't qualify for traditional implants due to severe bone loss.